Publication | Closed Access

Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate

Bone DiseaseUrologyBone HealthOsteopathyMedicineOsteoporosisBisphosphonate-associated OsteonecrosisProstatic DiseaseOncologyRisk FactorsOrthopaedic Surgery